News Releases
Jun 10, 2019- Strategic financing to advance the commercialization of Evofem's lead asset, Amphora® --
May 7, 2019Management to Host Conference Call at 11:00 a.m. EDT
-
Apr 30, 2019-- Conference Call Scheduled for 11:00 a.m. EDT --
-
Apr 23, 2019Top-line Data Expected in the Fourth Quarter of 2019
-
Apr 11, 2019Financing to fund pre-launch commercialization activities of Amphora® (L-lactic acid, citric acid, and potassium bitartrate), a novel, investigational non-hormonal, on-demand, female contraceptive
-
Mar 1, 2019Positive Phase 3 Amphora Results Enabling NDA Submission
-
Feb 19, 2019-- Conference Call Scheduled for 11:00 a.m. EST --